[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Changing the game
- To: liblicense-l@lists.yale.edu
- Subject: RE: Changing the game
- From: "Tony McSean" <tmcsean@hollar.co.uk>
- Date: Tue, 6 Oct 2009 10:21:25 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
I beg to differ with Dr Guedon when he says, "Results from private or corporation money: let each private source decide how it wants to see these results disseminated", which is rather more neocon in tone than many of his postings. Than the rest of this one, indeed. There are important exceptions to this which shade over from scholarly communication and into legitimate regulatory, notably in the area of pharma-sponsored drug trials. The many ways these can be, and are, suppressed and manipulated have important implications for public health, and to argue this case I can do no better than provide a link to Ben Goldacre's column in the Guardian last Saturday: http://www.guardian.co.uk/commentisfree/2009/oct/03/bad-science-verdict-drug-trials Tony Tony McSean +41 22 791 3539
- Prev by Date: RE: Changing the game
- Next by Date: RE: Changing the game
- Previous by thread: RE: Changing the game
- Next by thread: RE: Changing the game
- Index(es):